Grifols announced on Thursday that it has signed a strategic agreement with Swiss laboratory automation firm Inpeco to provide automated instrumentation, robotics, and software to transfusion medicine ...

The Jacobs School of Medicine and Biomedical Sciences considers the use of Top Hat to be a vital ... The University has negotiated a reduced price for the software license. Please purchase a lifetime ...

Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment; Funding led by gl ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI ...

A US-based pathology software provider has completed a $50m fund raise to advance its artificial intelligence (AI)-driven ...

The firm said that the money will support work with OEM partners and the expanded development and integration of artificial intelligence-based tools.

Several strides have been made in the field of artificial intelligence in the last decade, providing new opportunities for surgeons. AI in the workplace aids gastroenterologists in several ways, but ...

Proscia® has raised $50 million in its latest funding round, bringing its total funding to $130 million. This investment, led ...

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...

Accenture, Super Micro Computer, ServiceNow, Salesforce, Medtronic, Halliburton, and Tempus AI are the seven Artificial ...

All three of these founder-led businesses landed in the top 10 of Fast Company's 2025 Most Innovative Companies list.

Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and ...